Ensemble, améliorons la qualité en santé

Health technology assessment

High Intensity Focused Ultrasound (HIFU) for the treatment of localized prostate cancer

Aims of the
assessment

To evaluate the clinical effectiveness of HIFU therapy for early localized prostate cancer. HIFU therapy is applied as primary treatment for low and intermediate risk localized prostate cancer (T1-2 NxM0) in patients older than 70 years, and for local recurrence of prostate cancer after radiotherapy failure

Date December 2010
Method

Scientific literature analysis of expert opinion

Requested by

French Association for Urology

For more information

Contacts

Évaluation des actes professionnels

Sun Hae Lee-Robin Chef de service

Phone : 01.55.93.71.12

Fax : 01.55.93.74.35